edit

NEWROAD[1] is an Open Platform for European Networking and Repurposing of Oncological Assets and Drug. The project is part of Europe's Beating Cancer Plan[2][3]. The NEWROAD project is financed with the support of the EU4Health Programme, with a total budget of 1,635,325.00 Euros. The duration of the project is from November 2022 until October 2025.

Overview edit

The NEWROAD project is a significant endeavour aimed at establishing a European-wide capability for Systematic Drug Repurposing (SDR). This capability allows for the identification of promising therapeutic options for various diseases, with a focus on oncology. NEWROAD is built on an Augmented Intelligence (AuI) architecture layered upon Artificial Intelligence (AI) algorithms. It enables the repurposing of drugs for specific diseases or combinations of diseases.

The key functions of the NEWROAD platform are as follows:

  1. Development of Novel Therapies: The platform's primary function is the repurposing of drugs, initially targeting oncology. It identifies and assesses the potential of existing compounds for new therapeutic purposes.
  2. Sharing Clinical Data: NEWROAD facilitates the sharing of clinical data among entities in the European Community. This sharing is essential for research collaboration and informed decision-making.
  3. Open Collaborative Platform: NEWROAD serves as an open and collaborative platform for Systematic Drug Repurposing. It encourages researchers to engage, collaborate, and contribute their expertise to advance drug discovery efforts.

Consortium Partners edit

References edit

  1. ^ "Official site of NEWROAD project" (in Italian). Retrieved 2023-11-23.
  2. ^ "Europe's Beating Cancer Plan, with projects covering prevention, early detection, diagnosis and treatment, and improved quality of life for cancer patients and survivors". health.ec.europa.eu. Retrieved 2023-11-23.
  3. ^ "European Commission - NEWROAD project". health.ec.europa.eu. Retrieved 2023-11-23.
  4. ^ "University of Salerno (UNISA)".
  5. ^ "SoftMining" (in Italian). Retrieved 2023-11-23.
  6. ^ "Biovista | Drug Positioning and Prioritization - Home". Biovista | Drug Positioning and Prioritization. Retrieved 2023-11-23.
  7. ^ "Laminar Pharma I Pioneering biopharmaceutical company". laminarpharma. Retrieved 2023-11-23.